• Profile
Close

Empirical metronidazole for patients with severe bacterial infection: A systematic review with meta-analysis and trial sequential analysis

Acta Anaesthesiologica Scandinavica Feb 13, 2019

Petersen MW, et al. - In adults with serious bacterial infection of any origin, authors examined 1,753 subjects to analyze the patient-important advantages and disadvantages of empirical metronidazole vs placebo or no therapy in this systematic review with meta-analysis and trial sequential analysis. No difference in the primary outcome mortality (within 90 days) was observed. Secondary infections were seen in fewer candidates receiving metronidazole (relative risk 0.43). As the quality of evidence was very low for all consequences, they indicated a high risk of random errors due to a lack of data.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay